Clinical trials · Massachusetts
Medulloblastoma Recurrent clinical trials in Massachusetts
We’re tracking 2 recruiting medulloblastoma recurrent studies with a site in Massachusetts — including Phase 2 studies, each written for real people, not researchers.
Recruiting studies in Massachusetts
- NCT01356290RecruitingPhase 2
Anti-cancer blood-vessel treatment for relapsed childhood brain tumors
This trial tests a treatment that targets tumor blood-vessel growth to slow or shrink relapsed/progressive brain tumors in children. It may help if standard options are no longer working.
Boston, MassachusettsAges Up to 19 years - NCT05096481RecruitingPhase 2
Vaccine trial for children with certain brain tumors
This Phase 2 study tests a vaccine made to target CMV (a virus) in order to treat children with medulloblastoma or newly diagnosed high-grade glioma/DIPG. If you’re eligible, you’d receive the study vaccine and the team would closely watch how well it’s tolerated and how your cancer responds.
Boston, MassachusettsAges 3–39
Medulloblastoma Recurrent trials by city in Massachusetts
Where these studies are running in Massachusetts
Institutions with a site for the recruiting medulloblastoma recurrent studies listed above.
- Dana-Farber Cancer Institute · 2 studies
What taking part in a medulloblastoma recurrent study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Medulloblastoma Recurrent trials in other states
Common questions
- Are there medulloblastoma recurrent clinical trials in Massachusetts?
- Yes. We're currently tracking 2 recruiting medulloblastoma recurrent studies with a site in Massachusetts, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a medulloblastoma recurrent study in Massachusetts?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Massachusetts to take part?
- Not necessarily. These studies have a site in Massachusetts, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a medulloblastoma recurrent trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New medulloblastoma recurrent studies open in Massachusetts regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.